Skip to Main Content

Paper Details

Elevated serum levels of sialyl Lewis X (sLe<sup>X</sup>) and inflammatory mediators in patients with breast cancer.
Breast Cancer Res Treat
14
2019
DCIS, IP-10, MBC, MCP-1, breast cancer, breast tumor, cancer, carbohydrate, ductal carcinoma in situ, immune cells, invasive, invasive breast cancer, invasive cancer, metastatic breast cancer, non-metastatic breast cancer, patient, patients, sLeX, serum MCP-1, serum sLeX, sialyl, sialyl Lewis X
Author NameAffiliation
Yu ShenThe University of Texas MD Anderson Cancer Center
Naoto T UenoMorgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center
Naoto T UenoThe University of Texas MD Anderson Cancer Center
Massimo CristofanilliMorgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center
Massimo CristofanilliThe University of Texas MD Anderson Cancer Center
Massimo CristofanilliFeinberg School of Medicine
James M ReubenMorgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center
James M ReubenThe University of Texas MD Anderson Cancer Center
  • 1 - 8

Datasets

Release 1.2